한국어
English
日本語
中文(简体)
Arimidex Tablets (Anastrozole)
1mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Anastrozole is a hormone-regulating ingredient used in the treatment of breast cancer.
MFDS ingredient code M286651
Anastrozole is a non-steroidal aromatase inhibitor that suppresses the production of the female hormone estrogen. It is primarily used in the treatment of hormone-dependent breast cancer in postmenopausal women. It plays a role in preventing estrogen from promoting the growth of cancer cells.
Anastrozole blocks the action of the enzyme aromatase, which produces estrogen in the body. As a result, estrogen levels drop, inhibiting the growth of breast cancer cells. Consequently, it slows down or stops the progression of cancer.
Approved uses differ by product. Check each product's information for its actual use.
Anastrozole is a non-steroidal aromatase inhibitor with a structure that does not resemble steroids, demonstrating selective and potent inhibitory effects compared to other aromatase inhibitors. Additionally, it is primarily used in postmenopausal women, with limited effectiveness in premenopausal women.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.